Market Cap 354.62B
Revenue (ttm) 56.33B
Net Income (ttm) 4.28B
EPS (ttm) N/A
PE Ratio 19.50
Forward PE 16.02
Profit Margin 7.59%
Debt to Equity Ratio 11.71
Volume 5,889,300
Avg Vol 5,905,898
Day's Range N/A - N/A
Shares Out 1.77B
Stochastic %K 88%
Beta 0.58
Analysts Strong Sell
Price Target $207.19

Latest News on ABBV

AbbVie Appears Ready To Move Higher

Feb 18, 2025, 10:55 PM EST - 3 days ago

AbbVie Appears Ready To Move Higher


The Big 3: ABBV, EA, CEG

Feb 14, 2025, 11:58 AM EST - 8 days ago

The Big 3: ABBV, EA, CEG

EA CEG


AbbVie: An Undervalued Dividend Aristocrat

Feb 14, 2025, 11:00 AM EST - 8 days ago

AbbVie: An Undervalued Dividend Aristocrat


AbbVie Declares Quarterly Dividend

Feb 13, 2025, 11:57 AM EST - 9 days ago

AbbVie Declares Quarterly Dividend


Buy, Sell, Or Hold ABBV Stock At $185?

Feb 3, 2025, 9:25 AM EST - 19 days ago

Buy, Sell, Or Hold ABBV Stock At $185?


2 Undervalued Dividend Stocks Ready For A Major Comeback

Feb 2, 2025, 7:30 AM EST - 20 days ago

2 Undervalued Dividend Stocks Ready For A Major Comeback

NSC


AbbVie Inc. (ABBV) Q4 2024 Earnings Call Transcript

Jan 31, 2025, 12:26 PM EST - 21 days ago

AbbVie Inc. (ABBV) Q4 2024 Earnings Call Transcript


AbbVie: Q4 2024 Earnings Preview And Update On Emraclidine

Jan 26, 2025, 7:24 AM EST - 27 days ago

AbbVie: Q4 2024 Earnings Preview And Update On Emraclidine


My Near-Perfect Retirement Dividend Portfolio

Jan 24, 2025, 7:30 AM EST - 4 weeks ago

My Near-Perfect Retirement Dividend Portfolio

CSL DIVO ELS JEPI MO MPLX NOC


What Can The Dividend Kings Deliver In 2025?

Jan 24, 2025, 3:14 AM EST - 4 weeks ago

What Can The Dividend Kings Deliver In 2025?

ABM ABT ADM ADP AWR BDX BKH


AbbVie Completes Acquisition of Nimble Therapeutics

Jan 23, 2025, 9:16 AM EST - 4 weeks ago

AbbVie Completes Acquisition of Nimble Therapeutics


Top 4 Immunology Stocks Poised For Growth In 2025

Jan 19, 2025, 4:54 PM EST - 4 weeks ago

Top 4 Immunology Stocks Poised For Growth In 2025

BMY TEVA SNY


Income & Growth: 3 Of The Best Dividend Stocks For Any Market

Jan 17, 2025, 7:30 AM EST - 5 weeks ago

Income & Growth: 3 Of The Best Dividend Stocks For Any Market

KO TRP


Alzamend Neuro to Present at the Sequire Investor Summit

Jan 15, 2025, 8:00 AM EST - 5 weeks ago

Alzamend Neuro to Present at the Sequire Investor Summit


AbbVie Has Immense Cash Flow Potential

Jan 14, 2025, 5:08 AM EST - 5 weeks ago

AbbVie Has Immense Cash Flow Potential